Correlation Between Soleno Therapeutics and Endonovo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Soleno Therapeutics and Endonovo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Soleno Therapeutics and Endonovo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Soleno Therapeutics and Endonovo Therapeutics, you can compare the effects of market volatilities on Soleno Therapeutics and Endonovo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Soleno Therapeutics with a short position of Endonovo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Soleno Therapeutics and Endonovo Therapeutics.

Diversification Opportunities for Soleno Therapeutics and Endonovo Therapeutics

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Soleno and Endonovo is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Soleno Therapeutics and Endonovo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Endonovo Therapeutics and Soleno Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Soleno Therapeutics are associated (or correlated) with Endonovo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Endonovo Therapeutics has no effect on the direction of Soleno Therapeutics i.e., Soleno Therapeutics and Endonovo Therapeutics go up and down completely randomly.

Pair Corralation between Soleno Therapeutics and Endonovo Therapeutics

Given the investment horizon of 90 days Soleno Therapeutics is expected to generate 1.88 times more return on investment than Endonovo Therapeutics. However, Soleno Therapeutics is 1.88 times more volatile than Endonovo Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Endonovo Therapeutics is currently generating about 0.01 per unit of risk. If you would invest  508.00  in Soleno Therapeutics on September 12, 2024 and sell it today you would earn a total of  4,227  from holding Soleno Therapeutics or generate 832.09% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Soleno Therapeutics  vs.  Endonovo Therapeutics

 Performance 
       Timeline  
Soleno Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Soleno Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Soleno Therapeutics is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Endonovo Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Endonovo Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's fundamental indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Soleno Therapeutics and Endonovo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Soleno Therapeutics and Endonovo Therapeutics

The main advantage of trading using opposite Soleno Therapeutics and Endonovo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Soleno Therapeutics position performs unexpectedly, Endonovo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endonovo Therapeutics will offset losses from the drop in Endonovo Therapeutics' long position.
The idea behind Soleno Therapeutics and Endonovo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Commodity Directory
Find actively traded commodities issued by global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges